Feb. 19, 2010, Vol. 36 No. 6

by Kirsten Goldberg — last modified 2010-02-19 13:38

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation. FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds. FDA Approves Rituxan For CLL.

Welcome. Please log in to download the newsletter if you are a subscriber. You can use the log in box in the right column. If not a subscriber, please subscribe or get a one day pass using the links below.

Click here to subscribe

Click here to get a one day pass

Log in: Login Name

Password

Cookies are not enabled. You must enable cookies before you can log in.; Forgot your password?

Google Ad Links

Google Ads

This site conforms to the following standards:

Section 508
WCAG
Valid XHTML
Valid CSS
Usable in any browser